Literature DB >> 19956071

Mechanisms of bacterial virulence in pulmonary infections.

Samuel M Moskowitz1, Jeanine P Wiener-Kronish.   

Abstract

PURPOSE OF REVIEW: To consider the relevance to severe human lung infections of recently discovered virulence mechanisms of Staphylococcus aureus and Francisella tularensis. RECENT
FINDINGS: S. aureus has long been considered an opportunistic pathogen. However, due to the emergence of community-acquired methicillin-resistant S. aureus (CA-MRSA) strains that can readily infect and kill normal hosts, S. aureus must now be considered a potentially virulent pathogen. The evolution of S. aureus from an organism associated with asymptomatic nasopharyngeal colonization to one associated with community-acquired lethal infections may reflect horizontal acquisition of bacterial genes that enable efficient spread, aggressive host invasion, and effective immune evasion. Alleviating the burden of staphylococcal disease will require better understanding of host susceptibility and of staphylococcal virulence and antibiotic resistance. In contrast to the rapidly evolving staphylococcal virulence strategy, recent genomic analysis of F. tularensis has revealed a small set of bacterial genes associated with the marked virulence of its North American subspecies. This suggests that a relatively stable strategy of immune evasion underlies this pathogen's ability to establish serious life-threatening lung infections from a very small inoculum.
SUMMARY: Understanding bacterial pathogenesis will require additional research into both host susceptibility factors and bacterial virulence mechanisms, including horizontal gene transfer. Refinements in the molecular detection of bacteria in the clinical setting, as well as whole genome analysis of both pathogens and patients, are expected to aid in the understanding of bacterial-induced lung injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19956071      PMCID: PMC2845290          DOI: 10.1097/MCC.0b013e3283354710

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  33 in total

1.  Subunit composition of a bicomponent toxin: staphylococcal leukocidin forms an octameric transmembrane pore.

Authors:  George Miles; Liviu Movileanu; Hagan Bayley
Journal:  Protein Sci       Date:  2002-04       Impact factor: 6.725

2.  Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes.

Authors:  B König; G Prévost; Y Piémont; W König
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

3.  Reaction of rabbit leucocytes to staphylococcal (Panton-Valentine) leucocidin in vivo.

Authors:  S Szmigielski; J Jeljaszewicz; J Wilczynski; M Korbecki
Journal:  J Pathol Bacteriol       Date:  1966-04

4.  Genome-wide DNA microarray analysis of Francisella tularensis strains demonstrates extensive genetic conservation within the species but identifies regions that are unique to the highly virulent F. tularensis subsp. tularensis.

Authors:  Martien Broekhuijsen; Pär Larsson; Anders Johansson; Mona Byström; Ulla Eriksson; Eva Larsson; Richard G Prior; Anders Sjöstedt; Richard W Titball; Mats Forsman
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

5.  Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin.

Authors:  J P Wiener-Kronish; K H Albertine; M A Matthay
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

6.  Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.

Authors:  Thomas W Geisbert; Lisa E Hensley; Tom Larsen; Howard A Young; Douglas S Reed; Joan B Geisbert; Dana P Scott; Elliott Kagan; Peter B Jahrling; Kelly J Davis
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

7.  Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, and erythrogenic toxin A): generation of interleukin-8.

Authors:  B König; M Köller; G Prevost; Y Piemont; J E Alouf; A Schreiner; W König
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

8.  Pseudomonas aeruginosa-induced lung and pleural injury in sheep. Differential protective effect of circulating versus alveolar immunoglobulin G antibody.

Authors:  J F Pittet; M A Matthay; G Pier; M Grady; J P Wiener-Kronish
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

Review 9.  Waves of resistance: Staphylococcus aureus in the antibiotic era.

Authors:  Henry F Chambers; Frank R Deleo
Journal:  Nat Rev Microbiol       Date:  2009-09       Impact factor: 60.633

10.  Hydrostatic versus increased permeability pulmonary edema: diagnosis based on radiographic criteria in critically ill patients.

Authors:  D R Aberle; J P Wiener-Kronish; W R Webb; M A Matthay
Journal:  Radiology       Date:  1988-07       Impact factor: 11.105

View more
  4 in total

1.  Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus.

Authors:  Melissa J Karau; Mulualem E Tilahun; Ashton Krogman; Barbara A Osborne; Richard A Goldsby; Chella S David; Jayawant N Mandrekar; Robin Patel; Govindarajan Rajagopalan
Journal:  Virulence       Date:  2016-12-07       Impact factor: 5.882

Review 2.  The acute respiratory distress syndrome: pathogenesis and treatment.

Authors:  Michael A Matthay; Rachel L Zemans
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

3.  F. novicida-Infected A. castellanii Does Not Enhance Bacterial Virulence in Mice.

Authors:  Mateja Ozanic; Ivana Gobin; Martin Brezovec; Valentina Marecic; Zlatko Trobonjaca; Yousef Abu Kwaik; Marina Santic
Journal:  Front Cell Infect Microbiol       Date:  2016-05-18       Impact factor: 5.293

Review 4.  Autophagy markers as mediators of lung injury-implication for therapeutic intervention.

Authors:  Selvaraj Vishnupriya; Loganathan Chandramani Priya Dharshini; Kunnathur Murugesan Sakthivel; Rajan Radha Rasmi
Journal:  Life Sci       Date:  2020-08-21       Impact factor: 5.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.